MassVentures Awards Extend Biosciences with a START II Grant
A START II grant was awarded to Extend Biosciences in support of the Phase 1 clinical trial for EXT608. The company was one of only 5 awardees to receive the second phase of funding.
A START II grant was awarded to Extend Biosciences in support of the Phase 1 clinical trial for EXT608. The company was one of only 5 awardees to receive the second phase of funding.